Insights On Outsourced Drug Development

  1. Live-Cell Imaging Techniques 5/30/2023

    Explore how scientists are addressing research questions using live-cell imaging technology that has advanced in recent years to become more versatile and easily accessible.

  2. A New Approach For High-Resolution Full And Empty AAV Capsid Analysis 8/14/2023

    Utilize a high-throughput method for comprehensive AAV evaluation on a single CE platform for high-resolution full and empty AAV capsid analysis.

  3. Innovation Standardized – Bioseparation Methods For Biotherapeutics 7/5/2022

    Discover the most impactful standards in liquid chromatography (LC) for biotherapeutics. The standardizations include methods, columns, standards, and robustness.

  4. Automation Without Robotics: Elimination Of Sample Transfer Steps 5/4/2023

    A study was conducted to evaluate the SampleGenie system and determine if it is suitable for replacing several manual process steps. Explore the methods and results of this investigation.

  5. Characterize Lentiviral Vector Quality Attributes Using CE Platform Technology 8/14/2023

    Review this outline of a platform-based approach using capillary electrophoresis (CE) to mitigate the technical difficulties in characterizing LVVs for the assessment of multiple quality attributes.

  6. Automating Rapid High-Throughput LC-MS mAb Subunit Screening 8/23/2022

    We present a fully automated workflow for sample preparation and LC-MS analysis of mAbs obtained directly from complex samples such as spent cell culture media including host cell protein.

  7. Boosting In Vitro Toxicology Testing With Organ-Chips 4/9/2024

    Discover how Organ-Chips are enhancing preclinical testing, minimizing toxicity issues, and streamlining clinical trials for enhanced safety and efficiency.

  8. Workflow For Antibody Aggregate And Fragment Analysis 9/27/2022

    Characterizing mAb aggregate and fragment formation during drug formulation and establishing a suitable quality control process is essential. Learn about a complete workflow for antibody aggregate and fragment quantification.

  9. Early Development Considerations For Late-Stage NCE Success – Part Two 1/18/2024

    Discover how strategic partnerships, robust process development, and a keen awareness of supply chain vulnerabilities can pave the way to a successful clinical trial.

  10. The Future Of Microbial Manufacturing: Protein And Plasmid Production 9/9/2022

    Explore advances in the development of a one-part chemically defined microbial medium to simplify workflows and achieve high density cultures for recombinant protein or plasmid production applications.